Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can ICU teams predict which hemofiltration patients will develop pressure wounds?

NCT ID NCT07825727

Knowledge-focused Sponsor: Ogr. Uyesi Naile Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Critically ill patients on hemofiltration face high odds of pressure injuries from immobility, medical devices, and long treatment hours. Researchers at one Turkish hospital observe 109 adults receiving hemofiltration in intensive care, tracking skin condition, consciousness, nutrition, lab values, and device exposure over the treatment period and 72 hours after it ends. The goal is to map which clinical and treatment factors link to pressure injury risk, so nurses can spot high-risk patients sooner and adjust care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If researchers identify which factors raise pressure injury risk during hemofiltration, ICU teams could flag high-risk patients earlier and adjust nursing care to prevent painful, costly wounds.
What could go wrong
This observational study can only show associations, not cause and effect. Results from one hospital's ICU may not apply elsewhere, and the findings may not change practice if the risk factors are already well known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

109 people

The number who actually took part.

Started

Jul 2025

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being over 18 years of age, * Undergoing hemofiltration, * Patients whose participation in the study has been approved by their legal representative. Exclusion Criteria: * Planned intensive care unit stay of less than 48 hours, * Patients with impaired skin integrity due to different special treatments other than hemofiltration therapy (treatments such as ECMO, VAC, TPN, high-dose vasopressors that impair skin integrity not related to hemofiltration). (These non-hemofiltration-related impairments will be distinguished from the patient's medical history, nursing observation notes, and the opinion of the intensive care specialist. The clinical course in the patient's file will be used to determine the underlying cause.)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemofiltration are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

decubitus ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemofiltration Intensive care units (ICUS) Pressure ulcer (PU)

Contacts and locations

Locations

  • Fenerbahce University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.